TickerFactsScreenerDevelopers

Theriva Biologics, Inc. (TOVX) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2010: $12.0K2011: $02012: $10.0K2013: $36.0K2014: $48.0K2015: $501.0K2016: $569.0K2017: $212.0K2018: $7.0K2019: $02020: $9.0K2021: $14.0K2022: $116.0K2023: $202.0K2024: $1.0K2025: $35.0K$35.0K
2010Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$35.0K+3400.0%
2024$1.0K-99.5%
2023$202.0K+74.1%
2022$116.0K+728.6%
2021$14.0K+55.6%
2020$9.0K—
2019$0-100.0%
2018$7.0K-96.7%
2017$212.0K-62.7%
2016$569.0K+13.6%
2015$501.0K+943.8%
2014$48.0K+33.3%
2013$36.0K+260.0%
2012$10.0K—
2011$0-100.0%
2010$12.0K—